0001741042-20-000001.txt : 20200519 0001741042-20-000001.hdr.sgml : 20200519 20200518182600 ACCESSION NUMBER: 0001741042-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200518 EFFECTIVENESS DATE: 20200519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nutcracker Therapeutics, Inc. CENTRAL INDEX KEY: 0001741042 IRS NUMBER: 823039939 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367232 FILM NUMBER: 20891091 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 540 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: (510) 473-8478 MAIL ADDRESS: STREET 1: 5858 HORTON STREET, SUITE 540 CITY: EMERYVILLE STATE: CA ZIP: 94608 D 1 primary_doc.xml X0708 D LIVE 0001741042 Nutcracker Therapeutics, Inc. 5858 HORTON STREET, SUITE 540 EMERYVILLE CA CALIFORNIA 94608 (510) 473-8478 DELAWARE None None Corporation true 2017 Igor Khandros 5858 Horton Street, Suite 540 Emeryville CA CALIFORNIA 94608 Executive Officer Director Robert Nelsen 5858 Horton Street, Suite 540 Emeryville CA CALIFORNIA 94608 Director Biotechnology Decline to Disclose 06b false 2020-05-08 false true true true false 0 60036840 13999990 46036850 false 5 0 0 0 false Nutcracker Therapeutics, Inc. Igor Khandros Igor Khandros Chief Executive Officer 2020-05-18